Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of America Great Health from 30 Jun 2014 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
America Great Health quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD history and change rate from 30 Jun 2014 to 31 Mar 2025.
  • America Great Health Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending 31 Mar 2025 was $5,709,609, a 21% decline year-over-year.
Source SEC data
View on sec.gov
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Change (%)

America Great Health Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $5,709,609 -$990,826 -21% 31 Mar 2025 10-Q 15 May 2025 2025 Q3
Q4 2024 $5,576,377 -$953,109 -21% 31 Dec 2024 10-Q 15 May 2025 2025 Q3
Q3 2024 $5,389,271 -$864,233 -19% 30 Sep 2024 10-Q 15 May 2025 2025 Q3
Q2 2024 $5,311,599 -$940,763 -22% 30 Jun 2024 10-Q 15 May 2025 2025 Q3
Q1 2024 $4,718,783 -$361,851 -8.3% 31 Mar 2024 10-Q 15 May 2025 2025 Q3
Q4 2023 $4,623,268 -$462,724 -11% 31 Dec 2023 10-Q 15 May 2025 2025 Q3
Q3 2023 $4,525,038 -$492,285 -12% 30 Sep 2023 10-Q 15 May 2025 2025 Q3
Q2 2023 $4,370,836 -$665,355 -18% 30 Jun 2023 10-Q 15 May 2025 2025 Q3
Q1 2023 $4,356,932 -$1,254,661 -40% 31 Mar 2023 10-Q 03 Jun 2024 2024 Q3
Q4 2022 $4,160,544 -$1,565,924 -60% 31 Dec 2022 10-Q 23 Feb 2024 2024 Q2
Q3 2022 $4,032,753 -$3,236,468 -406% 30 Sep 2022 10-Q/A 08 Feb 2024 2024 Q1
Q2 2022 $3,705,481 -$3,237,654 -692% 30 Jun 2022 10-K 25 Feb 2025 2024 FY
Q1 2022 $3,102,271 31 Mar 2022 10-Q 25 May 2022 2022 Q3
Q4 2021 $2,594,620 31 Dec 2021 10-Q 22 May 2023 2023 Q3
Q3 2021 $796,285 30 Sep 2021 10-Q 22 May 2023 2023 Q3
Q2 2021 $467,827 -$252,820 -118% 30 Jun 2021 10-K/A 08 Feb 2024 2023 FY
Q2 2020 $215,007 30 Jun 2020 10-K 31 Oct 2022 2022 FY
Q3 2015 $660,391 30 Sep 2015 10-Q 20 Jun 2016 2016 Q1
Q2 2015 $992,370 -$639,094 -181% 30 Jun 2015 10-Q 20 Jun 2016 2016 Q1
Q2 2014 $353,276 30 Jun 2014 10-K 13 Oct 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.